The Hindu Business Line : Ghadiyar joins Dabur India

"Dabur India has identified OTC as one of the growth drivers for the company and Mr Ghadiyar will lend his expertise in giving impetus to its growth," a press release said.

With an experience of over 25 years, Mr Ghadiyar has held several senior management positions, including those of Group Director, Parke Davis; Managing Director Reckitt-Piramal; and President and Executive Director of Johnson & Johnson in his earlier assignments.

In his last assignment he was the President and CEO of Morepen Laboratories.

More Stories on : People | Healthcare Products

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
E.I.D. Parry to retail branded sugar

Neuland Labs plans preferential offer to promoters

Sun Pharma issues zero coupon FCCBs to raise $225 m

SABMiller open to acquiring smaller regional brewers — Rules out picking up stake in UB

Yash Papers scouting for overseas investors

Biocon to make equity investments in Vaccinex of US

SPIC to hike stake in SPEL to over 50 pc

Shareholders okay ITC Hotels merger plan

SKF opens application development centre

Shreya Life to step up manufacturing capacity

Revised exit scheme for defunct companies planned

`Next few years will see DaimlerChrysler on growth path'

Man-machine mismatch affects Jessop revival

Candico eyeing jt ventures in Nepal, Bangladesh, Africa

Ghadiyar joins Dabur India